Literature DB >> 14624613

A general NMR method for rapid, efficient, and reliable biochemical screening.

Claudio Dalvit1, Elena Ardini, Maria Flocco, Gian Paolo Fogliatto, Nicola Mongelli, Marina Veronesi.   

Abstract

High-throughput screening is usually the method of drug-lead discovery. It is now well accepted that, for a functional assay, quality is more important than quantity. The ligand-based or protein-based NMR screening methodologies for detecting compounds binding to the macromolecular target of interest are now well established. A novel and sensitive NMR method for rapid, efficient, and reliable biochemical screening is presented. The method named 3-FABS (three fluorine atoms for biochemical screening) requires the labeling of the substrate with a CF(3) moiety and utilizes (19)F NMR spectroscopy for the detection of the starting and enzymatically modified substrates. The method allows for high-quality screening of large compound or natural product extract collections and for measuring their IC(50) values. Applications of this technique to the screening of inhibitors of the Ser/Thr kinase AKT1 and the protease trypsin are presented. In addition, an interesting application of 3-FABS to functional genomics is also presented.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14624613     DOI: 10.1021/ja038128e

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  20 in total

1.  Design, Synthesis and Application of Fluorine-Labeled Taxoids as 19F NMR Probes for the Metabolic Stability Assessment of Tumor-Targeted Drug Delivery Systems.

Authors:  Joshua D Seitz; Jacob G Vineberg; Longfei Wei; Jonathan F Khan; Brendan Lichtenthal; Chi-Feng Lin; Iwao Ojima
Journal:  J Fluor Chem       Date:  2015-03-01       Impact factor: 2.050

Review 2.  Application of NMR and molecular docking in structure-based drug discovery.

Authors:  Jaime L Stark; Robert Powers
Journal:  Top Curr Chem       Date:  2012

3.  Protein-observed (19)F-NMR for fragment screening, affinity quantification and druggability assessment.

Authors:  Clifford T Gee; Keith E Arntson; Andrew K Urick; Neeraj K Mishra; Laura M L Hawk; Andrea J Wisniewski; William C K Pomerantz
Journal:  Nat Protoc       Date:  2016-07-14       Impact factor: 13.491

4.  Strategic Incorporation of Fluorine into Taxoid Anticancer Agents for Medicinal Chemistry and Chemical Biology Studies.

Authors:  Iwao Ojima
Journal:  J Fluor Chem       Date:  2017-01-03       Impact factor: 2.050

5.  Affinity screening using competitive binding with fluorine-19 hyperpolarized ligands.

Authors:  Yaewon Kim; Christian Hilty
Journal:  Angew Chem Int Ed Engl       Date:  2015-02-20       Impact factor: 15.336

6.  NMR-Based Activity Assays for Determining Compound Inhibition, IC50 Values, Artifactual Activity, and Whole-Cell Activity of Nucleoside Ribohydrolases.

Authors:  Brian J Stockman; Abinash Kaur; Julia K Persaud; Maham Mahmood; Samantha F Thuilot; Melissa B Emilcar; Madison Canestrari; Juliana A Gonzalez; Shannon Auletta; Vital Sapojnikov; Wagma Caravan; Samantha N Muellers
Journal:  J Vis Exp       Date:  2019-06-30       Impact factor: 1.355

Review 7.  Perspectives on NMR in drug discovery: a technique comes of age.

Authors:  Maurizio Pellecchia; Ivano Bertini; David Cowburn; Claudio Dalvit; Ernest Giralt; Wolfgang Jahnke; Thomas L James; Steve W Homans; Horst Kessler; Claudio Luchinat; Bernd Meyer; Hartmut Oschkinat; Jeff Peng; Harald Schwalbe; Gregg Siegal
Journal:  Nat Rev Drug Discov       Date:  2008-09       Impact factor: 84.694

Review 8.  High-field solution NMR spectroscopy as a tool for assessing protein interactions with small molecule ligands.

Authors:  Andria L Skinner; Jennifer S Laurence
Journal:  J Pharm Sci       Date:  2008-11       Impact factor: 3.534

9.  Protein-Inhibitor Interaction Studies Using NMR.

Authors:  Rieko Ishima
Journal:  Appl NMR Spectrosc       Date:  2015

10.  Estimating protein-ligand binding affinity using high-throughput screening by NMR.

Authors:  Matthew D Shortridge; David S Hage; Gerard S Harbison; Robert Powers
Journal:  J Comb Chem       Date:  2008-10-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.